Willingness to pay: What's in a name?

PharmacoEconomics

Volumn 14, Issue 5, 1998, Pages 465-470

  Gafni, Amiram ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH ECONOMICS; MEASUREMENT; MEDICAL FEE; PRIORITY JOURNAL;

CANADA; COST-BENEFIT ANALYSIS; HEALTH EXPENDITURES; HUMANS;

EID: 0031759690     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199814050-00001     Document Type: Article

References (18)

1. Johannesson M, Jonsson B. Economic evaluation in health care: is there a role for cost-benefit analysis? Health Policy 1991; 17: 1-23
2. Pauly MV. Valuing health care benefits in monetary terms. In: Sloan FA, editor. Valuing health care. Cambridge (MA): Cambridge University Press, 1995: 99-124
3. Culyer AJ, Evans RG. Mark Pauly on welfare economics: normative rabbits from positive hats. J Health Econ 1996; 15: 243-51
4. Weinstein MC, Manning WG. Theoretical issues in cost-effectiveness analysis. J Health Econ 1997; 16: 121-8
5. Kenkel D. On valuing morbidity, cost-effectiveness analysis, and being rude. J Health Econ 1997; 16: 121-8
6. Gafni A, Birch S. Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med 1995; 40: 767-76
7. Gafni A. Proper preference-based outcome measures in economic evaluations of pharmaceutical interventions. Med Care 1996; 34 Suppl. 12: DS48-58
8. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical decision analysis. Philadelphia (PA): W.B. Saunders Co., 1980
9. Mooney G. The economics of health and medicine. Brighton: Wheatsheaf, 1992
10. Garber AM, Weinstein MC, Torrance GW, et al. Theoretical foundations of cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press, 1996: 25-53
11. Zeckhauser R. Procedures for valuing lives. Public Policy 1975; 23: 419-64
12. Schelling T. The life you save may be your own. In: Chase B, editor. Problems in public expenditures analysis. Washington, DC: The Brookings Institution, 1968: 127-76
13. Gafni A. Willingness-to-pay as a measure of benefits. Med Care 1991; 29: 1246-52
14. O'Brien B, Gafni A. When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making 1996; 16: 288-99
15. Mishan EJ. Elements of cost-benefit analysis. London: George Allen and Unwin Ltd, 1972
16. Drummond M, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
17. Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy 1997; 40: 199-215
18. O'Brien B, Goeree R, Gafni A, et al. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Med Care 1998; 36: 370-84